logo

For the Inventor, By the Inventor

Waltham, MA, United States of America

Morphic Therapeutic, Inc.


USPTO Granted Patents = 17


Trademarks = 2

Forward Citations = 63

Loading Chart...
Loading Chart...

30 inventors (with patents filed for the assignee):

goldMedal Fu-Yang Lin (17 out of 17 patents)

silverMedal Blaise S Lippa (17 out of 22 patents)

bronzeMedal Dawn M Troast (17 out of 17 patents)

4.  Aleksey I Gerasyuto (17 out of 25 patents)

5.  Bruce Nelsen Rogers (17 out of 49 patents)

6.  Matthew Gregory Bursavich (17 out of 25 patents)

7.  Bryce Alden Harrison (17 out of 21 patents)

8.  Kyle D Konze (16 out of 16 patents)

9.  Kristopher N Hahn (14 out of 14 patents)

10.  Mats A Svensson (14 out of 14 patents)

11.  Alexey Alexandrovich Lugovskoy (10 out of 52 patents)

12.  Cheng Zhong (10 out of 15 patents)

13.  Byungchan Kim (9 out of 10 patents)

14.  Tyler Day (9 out of 9 patents)

15.  Brian Sosa (8 out of 8 patents)


17 patents:

1. 12552786 - Inhibitors of αvβ6 integrin (2026-02-17),
2. 12528803 - Inhibitors of αvβ6 integrin (2026-01-20),
3. 12459942 - Inhibiting (α-v)(β-6) integrin (2025-11-04),
4. 12415796 - Inhibitors of (αv)(β6) integrin (2025-09-16),
5. 12221416 - Antagonists of human integrin α4β7 (2025-02-11),
6. 12145935 - Inhibitors of (α-v)(β-6) integrin (2024-11-19),
7. 11827621 - Inhibitors of (α-v)(β-6) integrin (2023-11-28),
8. 11795167 - Inhibitors of (α-v)(β-6) integrin (2023-10-24),
9. 11739087 - Inhibiting (α-v)(β-6) integrin (2023-08-29),
10. 11370773 - Inhibiting human integrin (alpha-4) (beta-7) (2022-06-28),
11. 11174228 - Antagonists of human integrin (α4)(β7) (2021-11-16),
12. 11104661 - Inhibiting human integrin (α-4) (β-7) (2021-08-31),
13. 11046685 - Inhibitors of (α-v)(β-6) integrin (2021-06-29),
14. 11046669 - Inhibitors of (α-v)(β-6) integrin (2021-06-29),
15. 11040955 - Inhibitors of (alpha-v)(beta-6) integrin (2021-06-22),
Company Overview
Morphic Therapeutic, Inc. is a biotechnology company based in Waltham, MA, specializing in the development of innovative therapies for serious diseases. The company focuses on harnessing its proprietary technology platform to create oral therapeutics that target integrins, a class of proteins involved in various biological processes. Morphic is dedicated to advancing its research in areas such as immunology and oncology, aiming to address unmet medical needs through its unique approach to drug development.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Morphic Therapeutic, Inc. USPTO Patent Assignee Logo
17 Patents

#86 in Waltham, MA

#1,150 in Massachusetts

#18,881 in US

#35,887 in the World

Waltham, MA (US)
Waltham, MA, United States of America

Morphic Therapeutic, Inc.

Forward Citations = 63

30 inventors:

goldMedal Fu-Yang Lin (17 out of 17 patents)

silverMedal Blaise S Lippa (17 out of 22 patents)

bronzeMedal Dawn M Troast (17 out of 17 patents)

4.  Aleksey I Gerasyuto (17 out of 25 patents)

5.  Bruce Nelsen Rogers (17 out of 49 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Morphic Therapeutic, Inc.. Retrieved from https://idiyas.com/company/morphic-therapeutic

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…